You are here

Home >

Financial Reform

Issue | Health Care

Fighting The High Cost Rx Drugs

Brand-name drug companies have been paying off generic drug makers to delay competition and keep prices high. This widespread pay-for-delay scheme needs to be put to an end. 

CFPB to announce overdraft fee investigation, unveil "penalty box" disclosure, possibly end $39 lattes.

Wednesday, February 22, 2012
By | Alex Corkett
Program Associate

The new CFPB took over in July 2011 as primary supervisor and enforcer for the (over 100) biggest banks. Director Cordray's inquiry into checking account overdraft practices is an important step that will also require greater fee transparency, so consumers are more aware of bank practices.

Report | USPIRG Education Fund | Financial Reform

Ten Reasons Why We Need the Consumer Financial Protection Bereau Now

For years leading up to the 2008 financial collapse, federal bank regulators ignored numerous warnings of increasingly predatory mortgage practices, credit card tricks and unfair overdraft policies used by banks. The banks were earning billions from “gotcha” practices. Incredibly, bank regulators actively encouraged this behavior, arguing it was profitable and kept banks safe.

Resource | Budget, Consumer Protection, Democracy, Financial Reform, Food, Health Care, Higher Ed, Safe Energy, Solid Waste, Tax, Transportation

TOY SAFETY

Thousands of toys are on the market, each promising to educate or entertain our children. Unfortunately, not every toy is safe. Toy buyers can help protect children from injury by being careful, vigilant shoppers.

Resource | Budget, Consumer Protection, Democracy, Financial Reform, Food, Health Care, Higher Ed, Safe Energy, Solid Waste, Tax, Transportation

Beat High Bank Fees

Banks rely on consumer indifference when they raise fees. They count on consumers not shopping around. PIRG’s Big Banks, Bigger Fees reports routinely find that small banks and credit unions are not following the big banks’ lead; they still offer many free or low cost accounts.

Subscribe to RSS - Financial Reform

Tools & Resources

PRIORITY ACTION

When Big Pharma pays off their competition to keep them from selling lower priced generic drugs, we all pay. Each year this costs Americans an added $3.5 billion.

Take Action

Support Us

Your donation supports NMPIRG’s work to stand up for consumers on the issues that matter, especially when powerful interests are blocking progress.

donate today

Consumer Alerts

Join our network and stay up to date on our campaigns, get important consumer updates and take action on critical issues.